Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasms 1

Interventions

pembrolizumab 17 Bevacizumab 12 Standard of Care 10 Cyclophosphamide 9 Carboplatin 9 Doxorubicin 7 Cetuximab 7 Nivolumab 6 Exercise 6 olaparib 5 atezolizumab 5 Rituximab 5 Radiotherapy 5 Pemetrexed 5 Fluorouracil 5 Cisplatin 5 durvalumab 4 dostarlimab 4 abemaciclib 4 Temozolomide 4 Prednisone 4 Paclitaxel 4 Leucovorin 4 Blood Specimen Collection 4 venetoclax 3 temsirolimus 3 talazoparib 3 pertuzumab 3 obinutuzumab 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × FAPI-46 × 30 days × Clear all

NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡